Mast cell stabilizers are primarily prescribed for which condition?

Mast cell stabilizers are primarily used to manage and prevent symptoms associated with allergic conditions, particularly asthma. They work by inhibiting the release of mediators from mast cells, which are involved in allergic responses and bronchoconstriction. Exercise-induced asthma occurs when physical activity triggers bronchoconstriction in sensitive individuals, often due to an allergic response.

By using mast cell stabilizers, patients can reduce the incidence of asthma symptoms that are specifically triggered by exercise. These medications help maintain better airway stability during physical exertion, making them a suitable choice for those at risk of exercise-induced bronchoconstriction.

Other conditions listed, such as chronic bronchitis, acute respiratory distress, and cystic fibrosis, typically do not respond to mast cell stabilizers in the same way. Chronic bronchitis is primarily treated with bronchodilators and corticosteroids, acute respiratory distress involves different treatment protocols including oxygen therapy and mechanical ventilation, and cystic fibrosis management focuses on mucus clearance and pancreatic enzyme replacement rather than mast cell stabilization.